Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ARGAN INC
Report date October 15, 2019 · Filed January 08, 2020
Section 16 reporting ended · disclosed 2020-01-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Electrigen Limited | 27,965 |
Reported balance
Holding disclosure · report date 2019-10-15 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 27,965 F1: Electrigen Limited ("Electrigen") acquired the common stock of the Issuer in exchange for Electrigen's ownership interest in Atlantic Projects Company Limited having an estimated value of $917,531.65. The Reporting Person is 50% owner and director of Electrigen; therefore, the Reporting Person may be deemed to indirectly beneficially own the shares owned by Electrigen. |
| Stock Options to purchase Common StockSEC Table II · derivative / convertible security | Direct | 35,000 |
Reported balance
Holding disclosure · report date 2019-10-15 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 35,000 F2: As of the date of this filing, the total number of stock options owned by the Reporting Person includes options to acquire an aggregate number of 35,000 shares of the Issuer's common stock as follows: 1) options to purchase 5,000 shares awarded on 4/2/12 at an exercise price per share of $16.47; 2) options to purchase 10,000 shares awarded on 12/18/12 at an exercise price per share of $18.87; 3) options to purchase 10,000 shares awarded on 12/17/13 at an exercise price per share of $26.88; and 4) options to purchase 10,000 shares awarded on 12/11/14 at an exercise price per share of $31.82. Each set of options became exercisable on the first anniversary of the corresponding award date. All of these stock options will expire on 10/15/20. |
Filing footnotes · ownership attribution and instrument terms
F1: Electrigen Limited ("Electrigen") acquired the common stock of the Issuer in exchange for Electrigen's ownership interest in Atlantic Projects Company Limited having an estimated value of $917,531.65. The Reporting Person is 50% owner and director of Electrigen; therefore, the Reporting Person may be deemed to indirectly beneficially own the shares owned by Electrigen.
F2: As of the date of this filing, the total number of stock options owned by the Reporting Person includes options to acquire an aggregate number of 35,000 shares of the Issuer's common stock as follows: 1) options to purchase 5,000 shares awarded on 4/2/12 at an exercise price per share of $16.47; 2) options to purchase 10,000 shares awarded on 12/18/12 at an exercise price per share of $18.87; 3) options to purchase 10,000 shares awarded on 12/17/13 at an exercise price per share of $26.88; and 4) options to purchase 10,000 shares awarded on 12/11/14 at an exercise price per share of $31.82. Each set of options became exercisable on the first anniversary of the corresponding award date. All of these stock options will expire on 10/15/20.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 16, 2016 Filed Dec 19, 2016 21:05 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 10,000 | $70.33 | $703,300.00 |
DisclosureSEC source: 0001104659-16-162817 · a4.xml · nonDerivative · entry 2 Sherras Brian R · CIK 0001545637 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · shares: On December 16, 2016, the Reporting Person sold 10,000 shares of the Issuer's common stock on the open market at a price of $70.33 per share. Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 21:05 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 10,000 | $16.47 | $164,700.00 |
DisclosureSEC source: 0001104659-16-162817 · a4.xml · nonDerivative · entry 1 Sherras Brian R · CIK 0001545637 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On December 16, 2016, the Reporting Person exercised his stock option received on April 2, 2012 to purchase 10,000 shares of the Issuer's common stock at a price of $16.47 per share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.